论文信息 - CYFRA 21‐1: A new marker in lung cancer - 字舞流文

CYFRA 21‐1: A new marker in lung cancer

Background. It is known that cytokeratin 19 is particularly abundant in carcinoma of the lung.

H Dienemann | P. Stieber | D. Nagel | P Stieber | A Fateh-Moghadam | D Nagel | U Hasholzner | W Meier | H Bodenmüller | L Sunder-Plassmann | H. Bodenmüller | U. Hasholzner | A. Fateh‐Moghadam | Ludger Sunder‐Plassmann | Hendrik Dienemann | Werner Meier | Ludger Sunder-Plassmann

[1] B. Milleron,et al. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. , 1985, Chest.

[2] W. Eiermann,et al. Significance of Bone Alkaline Phosphatase, CA 15-3 and CEA in the Detection of Bone Metastases During the Follow-Up of Patients Suffering from Breast Carcinoma , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[3] T. Stigbrand,et al. Diversity in immunoreactivity of tumor-derived cytokeratin monoclonal antibodies. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4] S. Wagenaar,et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. , 1988, Cancer research.

[5] S. Wagenaar,et al. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. , 1987, Cancer research.

[6] R. Moll,et al. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. , 1984, The American journal of pathology.